Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis
- PMID: 36509928
- DOI: 10.1007/s12020-022-03257-8
Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis
Abstract
Purpose: The immune environment represents a new, but little explored, tool for understanding neuroendocrine neoplasms (NENs) behavior. An immunosuppressed microenvironment is hypothesized to promote NENs progression. A missing profiling of circulating leukocyte and peripheral blood mononuclear cells (PBMCs) subpopulations would open new perspectives in the still limited diagnostic-therapeutic management of NENs.
Methods: A cross-sectional case-control pilot study was performed recruiting 30 consecutive subjects: 15 patients naïve to treatment, with histologically proven gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and 15 healthy controls, matched for age and sex. PBMCs subpopulations were studied by flow cytometry. Soluble Tie2 (sTie2), Angiopoietin-1 (Ang-1), Angiopoietin-2 (Ang-2) were evaluated by ELISA.
Results: Immune cell profiling revealed a significant lower CD3-CD56+ natural killer (NK) cell count in NETs vs controls (p = 0.04). NK subset analysis showed a reduced relative count of CD56+CD16+ NK cells (p =0.002) in NETs vs controls. Patients with NET showed a higher percentage of CD14+CD16++ non-classical monocytes (p = 0.01), and a lower percentage of CD14+CD16+ intermediate monocytes (p = 0.04). A decrease in percentage (p = 0.004) of CD4+ T-helper lymphocytes was found in NET patients. Evaluation of cellular and serum angiopoietin pathway mediators revealed in NET patients a higher relative count of Tie2-expressing monocytes (TEMs) (p < 0.001), and high levels of Ang-1 (p = 0.003) and Ang-2 (p = 0.002).
Conclusions: Patients with GEP-NET presented an immunosuppressed environment characterized by a low count of cytotoxic NK cells, a high count of anti-inflammatory non-classical monocytes, and a low count of T-helper lymphocytes. Higher levels of TEMs and angiopoietins suggest a crosstalk between innate immunity and angiogenic pathways in NETs.
Keywords: Angiogenesis; Angiopoietin; Immune profile; Neuroendocrine neoplasms; PBMC; sTie2.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.Endocr Relat Cancer. 2010 Oct 5;17(4):897-908. doi: 10.1677/ERC-10-0020. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20696814
-
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.Hepatology. 2013 Apr;57(4):1416-25. doi: 10.1002/hep.25965. Epub 2013 Feb 11. Hepatology. 2013. PMID: 22815256
-
Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.J Surg Oncol. 2016 Jul;114(1):91-8. doi: 10.1002/jso.24249. Epub 2016 Apr 25. J Surg Oncol. 2016. PMID: 27111031
-
Angiopoietins in angiogenesis.Cancer Lett. 2013 Jan 1;328(1):18-26. doi: 10.1016/j.canlet.2012.08.018. Epub 2012 Aug 23. Cancer Lett. 2013. PMID: 22922303 Review.
-
Update Overview of the Role of Angiopoietins in Lung Cancer.Medicina (Kaunas). 2021 Nov 1;57(11):1191. doi: 10.3390/medicina57111191. Medicina (Kaunas). 2021. PMID: 34833409 Free PMC article. Review.
Cited by
-
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues.Biomedicines. 2023 Mar 10;11(3):842. doi: 10.3390/biomedicines11030842. Biomedicines. 2023. PMID: 36979820 Free PMC article.
-
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia.Cancers (Basel). 2023 Jul 12;15(14):3592. doi: 10.3390/cancers15143592. Cancers (Basel). 2023. PMID: 37509255 Free PMC article.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous